Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€150.75

€150.75

-0.430%
-0.65
-0.430%
€173.22

€173.22

 
10:46 / Tradegate WKN: A2JH2F / Symbol: KRYS / Name: Krystal Biotech / Stock / Biotechnology & Medical Research / Small Cap /
Latest predictions
€187.60
22.04.24
1.65%
buy
€191.76
16.04.24
-7.43%
buy
€180.00
10.04.24
-7.60%
buy
14.03.24
-8.08%
buy
€179.60
27.02.24
-0.82%
buy
€161.18
27.02.24
-0.82%
buy
Best running prediction
€146.38
20.11.23
57.03%
buy
Your prediction

Krystal Biotech Stock

The price for the Krystal Biotech stock decreased slightly today. Compared to yesterday there is a change of -€0.650 (-0.430%).
With 16 Buy predictions and not the single Sell prediction the community is currently very high on Krystal Biotech.
As a result the target price of 173 € shows a slightly positive potential of 14.76% compared to the current price of 150.75 € for Krystal Biotech.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Krystal Biotech stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Krystal Biotech in the next few years

Pros
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Krystal Biotech vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Krystal Biotech -0.430% -5.405% -2.949% 85.767% 30.517% - -
Ardelyx Inc. 3.750% -5.482% -15.972% 32.578% 3.218% -12.905% -
Salarius Pharmaceuticals Inc. 4.250% -0.935% -18.462% -68.120% -23.604% -98.261% -99.994%
Brainstorm Cell 1.170% -0.896% -1.485% -81.710% 114.440% -80.717% -

Comments

Prediction Buy
Perf. (%) 1.65%
Target price 187.600
Change
Ends at 22.04.25

Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $200.00 price target on the stock.
Ratings data for KRYS provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -7.43%
Target price 191.760
Change
Ends at 16.04.25

Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $204.00 price target on the stock, up previously from $178.00.
Ratings data for KRYS provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -0.82%
Target price 179.595
Change
Ends at 27.02.25

Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target raised by analysts at Citigroup Inc. from $160.00 to $195.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat
Show more